Verdence Capital Advisors LLC Processa Pharmaceuticals, Inc. Transaction History

Verdence Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$0.44 - $0.73 $2,200 - $3,650	-5,000 Reduced 19.99%	20,012 $10,000
Q1 2023 Apr 24, 2023	SELL	$0.41 - $1.3 $14,297 - $45,333	-34,872 Reduced 58.23%	25,012 $12,000
Q1 2022 May 02, 2022	SELL	$3.01 - $5.21 $10,062 - $17,417	-3,343 Reduced 5.29%	59,884 $180,000
Q4 2021 Jan 26, 2022	SELL	$4.03 - $8.42 $42,552 - $88,906	-10,559 Reduced 14.31%	63,227 $310,000
Q3 2021 Nov 12, 2021	BUY	$5.28 - $8.61 $389,590 - $635,297	73,786 New	73,786 $632,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $16.2M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Verdence Capital Advisors LLC with notifications on news.